Literature DB >> 27015447

Statins and portal hypertension: A tale of two models.

Juan P Arab1,2, Vijay H Shah1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27015447     DOI: 10.1002/hep.28567

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  A New Hepatoprotective Effect of Statins: Are They Always Safe for the Liver?

Authors:  Mahmoud Slim; Esperanza Ruiz-Cabello; Mercedes Robles-Díaz; M Isabel Lucena; Raúl J Andrade
Journal:  Am J Gastroenterol       Date:  2017-02       Impact factor: 10.864

Review 2.  Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.

Authors:  Jose Ignacio Vargas; Marco Arrese; Vijay H Shah; Juan Pablo Arab
Journal:  Curr Gastroenterol Rep       Date:  2017-09

3.  Statins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studies.

Authors:  Yaqin Wang; Jianping Xiong; Meng Niu; Xiaowei Chen; Long Gao; Qirun Wu; Kechuang Zheng; Ke Xu
Journal:  Oncotarget       Date:  2017-07-27

Review 4.  Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions.

Authors:  Malek Kreidieh; Rachelle Hamadi; Mira Alsheikh; Hassan Al Moussawi; Liliane Deeb
Journal:  Gastroenterology Res       Date:  2022-02-25

Review 5.  Current and Emerging Approaches for Hepatic Fibrosis Treatment.

Authors:  Jingguo Li; Biguang Tuo
Journal:  Gastroenterol Res Pract       Date:  2021-07-16       Impact factor: 2.260

Review 6.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives.

Authors:  Natascha Roehlen; Emilie Crouchet; Thomas F Baumert
Journal:  Cells       Date:  2020-04-03       Impact factor: 6.600

7.  Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.

Authors:  Yue Gu; Xueqin Yang; Hang Liang; Deli Li
Journal:  BMC Gastroenterol       Date:  2019-12-30       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.